Articole cu mandate pentru acces public - Nazzareno GalieAflați mai multe
Nu sunt disponibile nicăieri: 4
Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study
BA Maron, EL Brittain, E Hess, SW Waldo, AE Barón, S Huang, ...
The Lancet Respiratory Medicine 8 (9), 873-884, 2020
Mandate: US National Institutes of Health, US Department of Veterans Affairs
Diagnosis, treatment, and clinical management of pulmonary arterial hypertension in the contemporary era: a review
BA Maron, N Galiè
JAMA cardiology 1 (9), 1056-1065, 2016
Mandate: US National Institutes of Health, American Heart Association
Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI2) Receptor Agonist in Pulmonary Arterial …
IR Preston, RN Channick, K Chin, L Di Scala, HW Farber, S Gaine, ...
The Journal of Heart and Lung Transplantation 37 (3), 401-408, 2018
Mandate: US National Institutes of Health
Eisenmenger syndrome and pulmonary arterial hypertension in adults with congenital heart disease
MA Gatzoulis, R Barst, J Fineman, N Galie
Current Medical Research and Opinion 23 (sup2), S19-S25, 2007
Mandate: British Heart Foundation
Disponibile undeva: 49
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …
M Humbert, G Kovacs, MM Hoeper, R Badagliacca, RMF Berger, M Brida, ...
European heart journal 43 (38), 3618-3731, 2022
Mandate: Agence Nationale de la Recherche
Tadalafil therapy for pulmonary arterial hypertension
N Galiè, BH Brundage, HA Ghofrani, RJ Oudiz, G Simonneau, Z Safdar, ...
Circulation 119 (22), 2894-2903, 2009
Mandate: US National Institutes of Health
Updated treatment algorithm of pulmonary arterial hypertension
N Galiè, PA Corris, A Frost, RE Girgis, J Granton, ZC Jing, W Klepetko, ...
Journal of the American College of Cardiology 62 (25S), D60-D72, 2013
Mandate: US National Institutes of Health, Canadian Institutes of Health Research
Updated evidence-based treatment algorithm in pulmonary arterial hypertension
RJ Barst, JSR Gibbs, HA Ghofrani, MM Hoeper, VV McLaughlin, LJ Rubin, ...
Journal of the American College of Cardiology 54 (1_Supplement_S), S78-S84, 2009
Mandate: US National Institutes of Health
ERS statement on chronic thromboembolic pulmonary hypertension
M Delcroix, A Torbicki, D Gopalan, O Sitbon, FA Klok, I Lang, D Jenkins, ...
European Respiratory Journal 57 (6), 2021
Mandate: Agence Nationale de la Recherche
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
JDW Evans, B Girerd, D Montani, XJ Wang, N Galiè, ED Austin, G Elliott, ...
The lancet Respiratory medicine 4 (2), 129-137, 2016
Mandate: US National Institutes of Health, National Natural Science Foundation of …
Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism
SV Konstantinides, E Vicaut, T Danays, C Becattini, L Bertoletti, ...
Journal of the American College of Cardiology 69 (12), 1536-1544, 2017
Mandate: Federal Ministry of Education and Research, Germany
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
AE Frost, RJ Barst, MM Hoeper, HJ Chang, RP Frantz, Y Fukumoto, ...
The Journal of Heart and Lung Transplantation 34 (11), 1366-1375, 2015
Mandate: UK Medical Research Council
Three-versus two-drug therapy for patients with newly diagnosed pulmonary arterial hypertension
KM Chin, O Sitbon, M Doelberg, J Feldman, JSR Gibbs, E Grünig, ...
Journal of the American College of Cardiology 78 (14), 1393-1403, 2021
Mandate: US National Institutes of Health
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research
MM Hoeper, CSP Lam, JL Vachiery, J Bauersachs, C Gerges, IM Lang, ...
European heart journal 38 (38), 2869-2873, 2017
Mandate: Federal Ministry of Education and Research, Germany, National Medical …
Pulmonary arterial hypertension-related morbidity is prognostic for mortality
VV McLaughlin, MM Hoeper, RN Channick, KM Chin, M Delcroix, S Gaine, ...
Journal of the American College of Cardiology 71 (7), 752-763, 2018
Mandate: US National Institutes of Health, German Research Foundation
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
P Paolisso, L Bergamaschi, F Gragnano, E Gallinoro, A Cesaro, C Sardu, ...
Pharmacological research 187, 106597, 2023
Mandate: US National Institutes of Health
Use of β-blockers in pulmonary hypertension
F Perros, FS De Man, HJ Bogaard, F Antigny, G Simonneau, S Bonnet, ...
Circulation: Heart Failure 10 (4), e003703, 2017
Mandate: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism …
S Barco, M Russo, E Vicaut, C Becattini, L Bertoletti, J Beyer-Westendorf, ...
Clinical Research in Cardiology 108 (7), 772-778, 2019
Mandate: Federal Ministry of Education and Research, Germany
Risk assessment in pulmonary arterial hypertension: insights from the GRIPHON study
O Sitbon, KM Chin, RN Channick, RL Benza, L Di Scala, S Gaine, ...
The Journal of Heart and Lung Transplantation 39 (4), 300-309, 2020
Mandate: US National Institutes of Health, American Heart Association, German …
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study
M Beghetti, RN Channick, KM Chin, L Di Scala, S Gaine, HA Ghofrani, ...
European journal of heart failure 21 (3), 352-359, 2019
Mandate: US National Institutes of Health
Informațiile despre publicații și finanțare sunt alese automat de un program informatic